Biology Reference
In-Depth Information
67. Gupta A, Mulder J, Gomes I, Rozenfeld R, Bushlin I, Ong E, et al. Increased abundance of
opioid receptor heteromers after chronic morphine administration.
Sci Signal
2010;
3
:ra54.
68. Alhamadsheh MM, Connelly S, Cho A, Reixach N, Powers ET, Pan DW, et al. Potent
kinetic stabilizers that prevent transthyretin-mediated cardiomyocyte proteotoxicity.
Sci
Transl Med
2011;
3
:97ra81.
69. Alvarez-Curto E, Ward RJ, Pediani JD, Milligan G. Ligand regulation of the quaternary
organization of cell surface M3 muscarinic acetylcholine receptors analyzed by fluores-
cence resonance energy transfer (FRET) imaging and homogeneous time-resolved
FRET.
J Biol Chem
2010;
285
:23318-30.
70. Vischer HF, Nijmeijer S, Smit MJ, Leurs R. Viral hijacking of human receptors through
heterodimerization.
Biochem Biophys Res Commun
2008;
377
:93-7.
71. Mijares A, Lebesgue D, Wallukat G, Hoebeke J. From agonist to antagonist: Fab frag-
ments of an agonist-like monoclonal anti-beta(2)-adrenoceptor antibody behave as an-
tagonists.
Mol Pharmacol
2000;
58
:373-9.
72. Albizu L, Cottet M, Kralikova M, Stoev S, Seyer R, Brabet I, et al. Time-resolved
FRET between GPCR ligands reveals oligomers in native tissues.
Nat Chem Biol
2010;
6
:587-94.
73. Rajapakse HE, Gahlaut N, Mohandessi S, Yu D, Turner JR, Miller LW. Time-resolved
luminescence resonance energy transfer imaging of protein-protein interactions in living
cells.
Proc Natl Acad Sci USA
2010;
107
:13582-7.
74. Levoye A, Dam J, Ayoub MA, Guillaume JL, Couturier C, Delagrange P, et al. The
orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through
heterodimerization.
EMBO J
2006;
25
:3012-23.
75. Ciruela F, Casado V, Rodrigues RJ, Lujan R, Burgueno J, Canals M, et al. Presynaptic
control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor
heteromers.
J Neurosci
2006;
26
:2080-7.
76. Kern A, Albarran-Zeckler R, Walsh HE, Smith RG. Apo-ghrelin receptor forms
heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects
of DRD2 agonism.
Neuron
2012;
73
:317-32.
77. Epstein LH, Temple JL, Neaderhiser BJ, Salis RJ, Erbe RW, Leddy JJ. Food reinforce-
ment, the dopamine D2 receptor genotype, and energy intake in obese and nonobese
humans.
Behav Neurosci
2007;
121
:877-86.
78. Lohse MJ, Nuber S, Hoffmann C. Fluorescence/Bioluminescence resonance energy
transfer techniques to study g-protein-coupled receptor activation and signaling.
Pharmacol Rev
2012;
64
:299-336.
79. Liu CC, Schultz PG. Adding new chemistries to the genetic code.
Annu Rev Biochem
2010;
79
:413-44.
80. Liu W, Brock A, Chen S, Schultz PG. Genetic incorporation of unnatural amino acids
into proteins in mammalian cells.
Nat Methods
2007;
4
:239-44.
81. Ward RJ, Pediani JD, Milligan G. Ligand-induced internalization of the orexin OX(1)
and cannabinoid CB(1) receptors assessed via N-terminal SNAP and CLIP-tagging.
Br J
Pharmacol
2011;
162
:1439-52.
82. Kim SH, Gunther JR, Katzenellenbogen JA. Monitoring a coordinated exchange pro-
cess in a four-component biological interaction system: development of a time-resolved
terbium-based one-donor/three-acceptor multicolor FRET system.
J Am Chem Soc
2010;
:4685-92.
83. Schaferling M, Nagl S. Optical technologies for the read out and quality control of DNA
and protein microarrays.
Anal Bioanal Chem
2006;
385
:500-17.
84. Schaferling M, Nagl S. Forster resonance energy transfer methods for quantification of
protein-protein interactions on microarrays.
Methods Mol Biol
2011;
723
:303-20.
132
Search WWH ::
Custom Search